Novel 18F-Labeled Benzimidazolone-Based Radioligands as Highly Selective Sigma-2 Receptor Probes for Tumor Imaging

被引:1
作者
Wang, Jingqi [1 ]
Wang, Tao [1 ]
Mou, Tiantian [2 ]
Yang, Tao [3 ]
Gao, Xu [1 ]
An, Xiaodan [1 ]
Hu, Biao [2 ]
Zhang, Jinming [4 ]
Zhang, Xiaoli [2 ]
Deuther-Conrad, Winnie [5 ]
Huang, Yiyun [6 ]
Jia, Hongmei [1 ]
机构
[1] Beijing Normal Univ, Coll Chem, Key Lab Radiopharmaceut, Minist Educ, Beijing 100875, Peoples R China
[2] Capital Med Univ, Beijing Anzhen Hosp, Dept Nucl Med, Beijing 100029, Peoples R China
[3] Capital Med Univ, Beijing Tiantan Hosp, Dept Tradit Chinese Med, Beijing 100070, Peoples R China
[4] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Nucl Med, Beijing 100853, Peoples R China
[5] Helmholtz Zentrum Dresden Rossendorf HZDR, Inst Radiopharmaceut Canc Res, Dept Neuroradiopharmaceut, D-04318 Leipzig, Germany
[6] Yale Univ, Sch Med, Yale PET Ctr, Dept Radiol & Biomed Imaging, New Haven, CT 06520 USA
基金
中国国家自然科学基金;
关键词
P-GLYCOPROTEIN; BENZAMIDE ANALOGS; CYCLOSPORINE-A; BINDING-SITES; BRAIN; PROLIFERATION; EXPRESSION; CANCER; BLOOD; METABOLISM;
D O I
10.1021/acs.jmedchem.4c01315
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Novel sigma-2 (sigma(2)) receptor ligands with benzimidazolone and 5,6-dimethoxyisoindoline as pharmacophores were designed and synthesized. Compound 4 exhibited low nanomolar affinity for the sigma(2 )receptors (K-i(sigma(2)) = 2.30 nM) and high subtype selectivity (K-i(sigma(1))/K-i(sigma(2)) > 1500). Radioligand [F-18]4 was prepared in radiochemical yields of 18 +/- 7%, with >99% radiochemical purity and molar activity of 244 +/- 136 GBq/mu mol. Biodistribution and blocking studies in mice and small animal PET/CT imaging in rats indicated highly specific binding of [F-18]4 in organs known to express the sigma(2) receptors. Small animal PET/CT imaging with [F-18]4 showed clear visualization of the tumors in subcutaneous A549 lung cancer and U87MG glioma xenografts, and intracranial orthotopic U87MG glioma models. Co-administration of CM398 with [F-18]4 significantly reduced activity uptake in the tumors, indicating that [F-18]4 specifically binds to the sigma(2) receptors expressed in A549 and U87MG xenografts.
引用
收藏
页码:17392 / 17406
页数:15
相关论文
共 51 条
  • [1] Effect of ploidy, recruitment, environmental factors, and tamoxifen treatment on the expression of sigma-2 receptors in proliferating and quiescent tumour cells
    Al-Nabulsi, I
    Mach, RH
    Wang, LM
    Wallen, CA
    Keng, PC
    Sten, K
    Childers, SR
    Wheeler, KT
    [J]. BRITISH JOURNAL OF CANCER, 1999, 81 (06) : 925 - 933
  • [2] Structures of the σ2, receptor enable docking for bioactive ligand discovery
    Alon, Assaf
    Lyu, Jiankun
    Braz, Joao M.
    Tummino, Tia A.
    Craik, Veronica
    O'Meara, Matthew J.
    Webb, Chase M.
    Radchenko, Dmytro S.
    Moroz, Yurii S.
    Huang, Xi-Ping
    Liu, Yongfeng
    Roth, Bryan L.
    Irwin, John J.
    Basbaum, Allan, I
    Shoichet, Brian K.
    Kruse, Andrew C.
    [J]. NATURE, 2021, 600 (7890) : 759 - +
  • [3] Identification of the gene that codes for the σ2 receptor
    Alon, Assaf
    Schmidt, Hayden R.
    Wood, Michael D.
    Sahn, James J.
    Martin, Stephen F.
    Kruse, Andrew C.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (27) : 7160 - 7165
  • [4] Effect of cyclosporin A administration on the biodistribution and multipinhole μSPECT imaging of [123I]R91150 in rodent brain
    Blanckaert, P.
    Burvenich, I.
    Staelens, S.
    De Bruyne, S.
    Moerman, L.
    Wyffels, L.
    De Vos, F.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (03) : 446 - 453
  • [5] TMEM97 facilitates the activation of SOCE by downregulating the association of cholesterol to Orai1 in MDA-MB-231 cells
    Cantonero, C.
    Camello, P. J.
    Salido, G. M.
    Rosado, J. A.
    Redondo, P. C.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2021, 1866 (06):
  • [6] Assessment of Cellular Proliferation in Tumors by PET Using 18F-ISO-1
    Dehdashti, Farrokh
    Laforest, Richard
    Gao, Feng
    Shoghi, Kooresh I.
    Aft, Rebecca L.
    Nussenbaum, Brian
    Kreisel, Friederike H.
    Bartlett, Nancy L.
    Cashen, Amanda
    Wagner-Johnson, Nina
    Mach, Robert H.
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (03) : 350 - 357
  • [7] Drug transport to the brain:: Key roles for the efflux pump P-glycoprotein in the blood-brain barrier
    Demeule, M
    Régina, A
    Jodoin, J
    Laplante, A
    Dagenais, C
    Berthelet, F
    Moghrabi, A
    Béliveau, R
    [J]. VASCULAR PHARMACOLOGY, 2002, 38 (06) : 339 - 348
  • [8] Expression of multidrug-resistance P-glycoprotein (MDR1) in human brain tumors
    Demeule, M
    Shedid, D
    Beaulieu, É
    Del Maestro, RF
    Moghrabi, A
    Ghosn, PB
    Moumdjian, R
    Berthelet, F
    Beliveau, R
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (01) : 62 - 66
  • [9] INTERACTION OF 1,3-DI(2-(5-H-3 TOLYL) GUANIDINE WITH SIGMA-2 BINDING-SITES IN RAT-HEART MEMBRANE PREPARATIONS
    DUMONT, M
    LEMAIRE, S
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 209 (03) : 245 - 248
  • [10] Effect of structural modification in the amine portion of substituted aminobutyl-benzamides as ligands for binding σ1 and σ2 receptors
    Fan, Kuo-Hsien
    Lever, John R.
    Lever, Susan Z.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (06) : 1852 - 1859